HIGH-PREDICTIVITY IN VITRO PLATFORM FOR DRUG DEVELOPMENT

Startup
🇮🇹
  • Code:350
  • Sector: BIOTECHNOLOGIES
  • Geographical area startup: Centro-Nord Italia
  • Stratup turnover: MINORE DI € 1.000.000
Company specifications

Startup that develops, produces, and commercializes high-predictivity in vitro devices used for drug development and research. The devices feature an experimental environment closer to that of patients, enabling more relevant results for clinical testing and thus reducing the risk of costly late-stage failures. The devices are ready-to-use, easy to use, and compatible with traditional laboratory processes. The first products are available to selected partners and have attracted the interest of international customers in the biopharmaceutical research sector. The company holds all intellectual property relating to the underlying technology and manufacturing methods.

Target

The company is seeking an industrial partner in the pharmaceutical research and life sciences sector to accelerate growth.

Strenghts
  • Ten years of experience in cell biology, biomaterials, manufacturing, and startups
  • Scalability and high growth potential (Goal of 10+ million in revenue in 4 years)
  • Interest from companies in the tools, pharmaceutical, and CRO sectors
  • International patents (EU, USA, JP, CHI, INDIA) and solid IP

  • PIATTAFORMA IN VITRO AD ALTA PREDITTIVITÀ PER LO SVILUPPO DEI FARMACI
  • Request more information
    To receive a more detailed anonymous profile on this specific project, please fill in the following fields.
    Richiedi informazioni come:
    Company Private

    Contact and information

    Pursuant to and in accordance with Articles 6 and 13 of EU Regulation 2016/679 - GDPR

    * With respect to the information for the processing of personal data of YON Srl for the purpose B) DIRECT MARKETING (only by YON, not by third parties)

    After viewing the anonymous profile, if interest in the proposed project is confirmed, the signing of a specific standard Confidentiality Agreement will be required, through which the prospective interested party agrees to maintain strict confidentiality on the name of the company corresponding to the project of interest, the type of potential transaction, as well as any data and information that may be exchanged between the parties, as well as to always use "YON" as a conduit for any communication with the company of interest, which may preliminarily express or not express a willingness to proceed in the contact.

YON logo YON iscrizione newsletter

Receive a preview of new
M&A Opportunities!

Complimentary guide to M&A Transactions

Contattaci

Write to us

We are at your disposal.

Pursuant to and in accordance with Articles 6 and 13 of EU Regulation 2016/679 - GDPR

Compared with the Information for the processing of personal data of YON Srl for the purpose B) DIRECT MARKETING (for sending advertising or direct sales material or for carrying out market research, liking or commercial and promotional communication, newsletters, by automated means - e-mail, SMS)


YBS

YON Business Share

the B2B for M&A PROFESSIONALS

Write to us and we will get back to you as soon as possible !

Pursuant to and in accordance with Articles 6 and 13 of EU Regulation 2016/679 - GDPR

Compared with the Information for the processing of personal data of YON Srl for the purpose B) DIRECT MARKETING (for sending advertising or direct sales material or for carrying out market research, liking or commercial and promotional communication, newsletters, by automated means - e-mail, SMS)